The settlement funds are designated for services, programs, or initiatives that have demonstrably reduced the impact of the opioid epidemic within the municipal limits of Statesboro. Eligible uses may include prevention, treatment, recovery support, harm reduction, and education efforts.
Applications will be accepted starting August 18, 2025, and will remain open until all funds are fully distributed. Awards of up to $15,000 per applicant will be considered, with funding provided annually until the allocation is exhausted. A five-member review panel, comprised of community members and city staff, will evaluate applications and determine grant awards.
Organizations interested in applying for grant funding can pick up an application at Statesboro City Hall or download a copy below.
Completed applications and questions should be directed to Olympia Gaines.
The Statesboro Opioid Reimbursement Grant program is supported by funds from national and state-level opioid settlements, including:
National Distributors & Janssen/Johnson & Johnson Settlement (2022): Georgia opted into litigation, resulting in $636 million in combined settlements with major pharmaceutical distributors and manufacturers. The National Distributor Settlement funds will be disbursed on an 18-year plan, while the Janssen/J&J Settlement funds will be disbursed on a 9-year plan.
McKinsey Settlement (2021): Georgia joined a $13 million settlement with McKinsey & Company to combat opioid misuse. Funds are allocated to expand Medication Assisted Treatment (MAT) availability, increase detoxification services, reduce stigma, increase naloxone access, and expand naloxone training.